Stocks News

LAST PRICE
280.1300
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
263.5700/ 1
Ask / Lots
296.2300/ 1
Open / Previous Close
281.7300 / 280.1300
Day Range
Low 277.7100
High 283.4200
52 Week Range
Low 261.5900
High 473.5000
Volume
217,079
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 18, 2024
- Press Release: Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:06AM ET on Thursday Apr 18, 2024 by Dow Jones
  9:06AM ET on Thursday Apr 18, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
  HERCULES, Calif.--(BUSINESS WIRE)--April 18, 2024--
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:00AM ET on Thursday Apr 18, 2024 by Business Wire
  9:00AM ET on Thursday Apr 18, 2024 by Business Wire
  Companies Mentioned: BIO.B
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:00AM ET on Thursday Apr 18, 2024 by Dow Jones
  9:00AM ET on Thursday Apr 18, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  HERCULES, Calif.--(BUSINESS WIRE)--April 18, 2024--
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
Apr 15, 2024
- --Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322, from 10:21AM ET on Monday Apr 15, 2024 by MT Newswires
  10:21AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: BIO
  10:21 AM EDT, 04/15/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...
Apr 11, 2024
- DJ Oncocyte, Bio-Rad Partner on Global Launch of Transplant Assay, from 6:11PM ET on Thursday Apr 11, 2024 by Dow Jones
  6:11PM ET on Thursday Apr 11, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B, OCX
  
  By Stephen Nakrosis
  
  Oncocyte and Bio-Rad on Thursday said they agreed to a partnership agreement to commercialize the research use only GraftAssure assay.

Yesterday
- --BNP Paribas Exane Initiates Stevanato Group With Outperform Rating, from 18 hours ago by MT Newswires
  18 hours ago by MT Newswires
  Companies Mentioned: STVN
Apr 15, 2024
- --Truist Securities Adjusts Teleflex Price Target to $240 From $265, Hold Rating Kept, from 8:50AM ET on Monday Apr 15, 2024 by MT Newswires
  8:50AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: TFX
- --Stifel Upgrades Masimo to Buy From Hold, Raises Price Target to $170 From $148, from 6:41AM ET on Monday Apr 15, 2024 by MT Newswires
  6:41AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: MASI
Apr 8, 2024
- RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating, from 7:55AM ET on Monday Apr 08, 2024 by MT Newswires
  7:55AM ET on Monday Apr 08, 2024 by MT Newswires
  Companies Mentioned: RGEN
- Apple to Allow Other Payment Options for Music Apps in Europe; Appeals to Overturn Apple Watch Import Ban, from 7:43AM ET on Monday Apr 08, 2024 by MT Newswires
  7:43AM ET on Monday Apr 08, 2024 by MT Newswires
  Companies Mentioned: AAPL, MASI
Apr 4, 2024
- Stevanato Group Names Ugo Gay as Chief Operations Officer, from 10:21AM ET on Thursday Apr 04, 2024 by MT Newswires
  10:21AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: STVN
- Stevanato Group appoints Ugo Gay as Chief Operations Officer, from 8:00AM ET on Thursday Apr 04, 2024 by Business Wire
  8:00AM ET on Thursday Apr 04, 2024 by Business Wire
  Companies Mentioned: STVN
Apr 2, 2024
- Teleflex Incorporated Introduces the UroLift(TM) 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types, from 6:30AM ET on Tuesday Apr 02, 2024 by GlobeNewswire
  6:30AM ET on Tuesday Apr 02, 2024 by GlobeNewswire
  Companies Mentioned: TFX
Apr 1, 2024
- Masimo Responds to Claims by Shareholder Activist Politan Capital, from 9:19AM ET on Monday Apr 01, 2024 by MT Newswires
  9:19AM ET on Monday Apr 01, 2024 by MT Newswires
  Companies Mentioned: MASI
- Masimo Responds to Politan Capital's Nomination of Director Candidates and Refutes Politan's False Claims, from 8:00AM ET on Monday Apr 01, 2024 by Business Wire
  8:00AM ET on Monday Apr 01, 2024 by Business Wire
  Companies Mentioned: MASI

Bio Rad Laboratories Inc
NYSE:BIOUnited States

Search Criteria

Apr 18, 2024

Press Release: Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:06AM ET on Thursday Apr 18, 2024 by Dow Jones

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:00AM ET on Thursday Apr 18, 2024 by Business Wire

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:00AM ET on Thursday Apr 18, 2024 by Dow Jones

Apr 15, 2024

--Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322, from 10:21AM ET on Monday Apr 15, 2024 by MT Newswires

Apr 11, 2024

DJ Oncocyte, Bio-Rad Partner on Global Launch of Transplant Assay, from 6:11PM ET on Thursday Apr 11, 2024 by Dow Jones

Peers Headlines

Yesterday

--BNP Paribas Exane Initiates Stevanato Group With Outperform Rating, from 18 hours ago by MT Newswires

Apr 15, 2024

--Truist Securities Adjusts Teleflex Price Target to $240 From $265, Hold Rating Kept, from 8:50AM ET on Monday Apr 15, 2024 by MT Newswires

--Stifel Upgrades Masimo to Buy From Hold, Raises Price Target to $170 From $148, from 6:41AM ET on Monday Apr 15, 2024 by MT Newswires

Apr 8, 2024

RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating, from 7:55AM ET on Monday Apr 08, 2024 by MT Newswires

Apple to Allow Other Payment Options for Music Apps in Europe; Appeals to Overturn Apple Watch Import Ban, from 7:43AM ET on Monday Apr 08, 2024 by MT Newswires

Apr 4, 2024

Stevanato Group Names Ugo Gay as Chief Operations Officer, from 10:21AM ET on Thursday Apr 04, 2024 by MT Newswires

Stevanato Group appoints Ugo Gay as Chief Operations Officer, from 8:00AM ET on Thursday Apr 04, 2024 by Business Wire

Apr 2, 2024

Teleflex Incorporated Introduces the UroLift(TM) 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types, from 6:30AM ET on Tuesday Apr 02, 2024 by GlobeNewswire

Apr 1, 2024

Masimo Responds to Claims by Shareholder Activist Politan Capital, from 9:19AM ET on Monday Apr 01, 2024 by MT Newswires

Masimo Responds to Politan Capital's Nomination of Director Candidates and Refutes Politan's False Claims, from 8:00AM ET on Monday Apr 01, 2024 by Business Wire